147 related articles for article (PubMed ID: 21881218)
1. Animal model for schizophrenia that reflects gene-environment interactions.
Nagai T; Ibi D; Yamada K
Biol Pharm Bull; 2011; 34(9):1364-8. PubMed ID: 21881218
[TBL] [Abstract][Full Text] [Related]
2. [PolyI:C-induced neurodevelopmental animal model for schizophrenia].
Ibi D; Nagai T; Nabeshima T; Yamada K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):201-7. PubMed ID: 22256608
[TBL] [Abstract][Full Text] [Related]
3. Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood.
Ibi D; Nagai T; Koike H; Kitahara Y; Mizoguchi H; Niwa M; Jaaro-Peled H; Nitta A; Yoneda Y; Nabeshima T; Sawa A; Yamada K
Behav Brain Res; 2010 Jan; 206(1):32-7. PubMed ID: 19716847
[TBL] [Abstract][Full Text] [Related]
4. Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI:C treatment.
Nagai T; Kitahara Y; Ibi D; Nabeshima T; Sawa A; Yamada K
Behav Brain Res; 2011 Nov; 225(1):305-10. PubMed ID: 21835207
[TBL] [Abstract][Full Text] [Related]
5. Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice.
Lipina TV; Zai C; Hlousek D; Roder JC; Wong AH
J Neurosci; 2013 May; 33(18):7654-66. PubMed ID: 23637159
[TBL] [Abstract][Full Text] [Related]
6. [Perinatal innate immune activation and neuropsychological development].
Nagai T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Aug; 33(4):149-54. PubMed ID: 25069250
[TBL] [Abstract][Full Text] [Related]
7. Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood.
Ibi D; Nagai T; Kitahara Y; Mizoguchi H; Koike H; Shiraki A; Takuma K; Kamei H; Noda Y; Nitta A; Nabeshima T; Yoneda Y; Yamada K
Neurosci Res; 2009 Jul; 64(3):297-305. PubMed ID: 19447299
[TBL] [Abstract][Full Text] [Related]
8. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia.
Meyer U; Feldon J; Schedlowski M; Yee BK
Neurosci Biobehav Rev; 2005; 29(6):913-47. PubMed ID: 15964075
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and proteomic analyses of neonatal polyI:C-treated adult mice.
Kitagawa K; Nagai T; Yamada K
Neurosci Res; 2019 Oct; 147():39-47. PubMed ID: 31446906
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic effects of maternal immune activation and early postnatal milieu in mice mutant for the schizophrenia risk gene neuregulin-1.
O'Leary C; Desbonnet L; Clarke N; Petit E; Tighe O; Lai D; Harvey R; Waddington JL; O'Tuathaigh C
Neuroscience; 2014 Sep; 277():294-305. PubMed ID: 24969132
[TBL] [Abstract][Full Text] [Related]
11. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia.
Winter C; Djodari-Irani A; Sohr R; Morgenstern R; Feldon J; Juckel G; Meyer U
Int J Neuropsychopharmacol; 2009 May; 12(4):513-24. PubMed ID: 18752727
[TBL] [Abstract][Full Text] [Related]
12. Immune activation in lactating dams alters sucklings' brain cytokines and produces non-overlapping behavioral deficits in adult female and male offspring: A novel neurodevelopmental model of sex-specific psychopathology.
Arad M; Piontkewitz Y; Albelda N; Shaashua L; Weiner I
Brain Behav Immun; 2017 Jul; 63():35-49. PubMed ID: 28189716
[TBL] [Abstract][Full Text] [Related]
13. JNK signalling mediates aspects of maternal immune activation: importance of maternal genotype in relation to schizophrenia risk.
Openshaw RL; Kwon J; McColl A; Penninger JM; Cavanagh J; Pratt JA; Morris BJ
J Neuroinflammation; 2019 Jan; 16(1):18. PubMed ID: 30691477
[TBL] [Abstract][Full Text] [Related]
14. Behavioral phenotypes in schizophrenic animal models with multiple combinations of genetic and environmental factors.
Hida H; Mouri A; Noda Y
J Pharmacol Sci; 2013; 121(3):185-91. PubMed ID: 23449491
[TBL] [Abstract][Full Text] [Related]
15. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia.
Pletnikov MV; Ayhan Y; Nikolskaia O; Xu Y; Ovanesov MV; Huang H; Mori S; Moran TH; Ross CA
Mol Psychiatry; 2008 Feb; 13(2):173-86, 115. PubMed ID: 17848917
[TBL] [Abstract][Full Text] [Related]
16. Prospective Analysis of the Effects of Maternal Immune Activation on Rat Cytokines during Pregnancy and Behavior of the Male Offspring Relevant to Schizophrenia.
Lins BR; Hurtubise JL; Roebuck AJ; Marks WN; Zabder NK; Scott GA; Greba Q; Dawicki W; Zhang X; Rudulier CD; Gordon JR; Howland JG
eNeuro; 2018; 5(4):. PubMed ID: 30225350
[TBL] [Abstract][Full Text] [Related]
17. Prenatal and postnatal maternal contributions in the infection model of schizophrenia.
Meyer U; Schwendener S; Feldon J; Yee BK
Exp Brain Res; 2006 Aug; 173(2):243-57. PubMed ID: 16552558
[TBL] [Abstract][Full Text] [Related]
18. A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions.
Ishizuka K; Paek M; Kamiya A; Sawa A
Biol Psychiatry; 2006 Jun; 59(12):1189-97. PubMed ID: 16797264
[TBL] [Abstract][Full Text] [Related]
19. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling.
Meyer U; Murray PJ; Urwyler A; Yee BK; Schedlowski M; Feldon J
Mol Psychiatry; 2008 Feb; 13(2):208-21. PubMed ID: 17579604
[TBL] [Abstract][Full Text] [Related]
20. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans.
Hikida T; Jaaro-Peled H; Seshadri S; Oishi K; Hookway C; Kong S; Wu D; Xue R; Andradé M; Tankou S; Mori S; Gallagher M; Ishizuka K; Pletnikov M; Kida S; Sawa A
Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14501-6. PubMed ID: 17675407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
